Exposure to lipopolysaccharide (LPS) primes polymorphonuclear leucocytes (PMNL) for enhanced release of oxygen metabolities after subsequent stimulation. The metabolic response of human PMNL primed with LPS and stimulated with formylmethionyl-leucyl-phenylalanine (FMLP) was measured by chemiluminescence (CL) as a parameter for endotoxic activity. Polymyxin B (PMB) and monoclonal antibodies (MAbs) with specificity for lipid A were tested for inhibition of the priming effect of Re LPS of Salmonella minnesota R595, Rc LPS of Escherichia coli J5 and smooth LPS of E. coli O111. The CL response of PMNL primed with Re LPS or Rc LPS was higher than that of PMNL primed with smooth LPS. Pre-incubation of rough or smooth LPS with PMB caused dosedependent inhibition of priming of PMNL. Two IgM MAbs, 8-2 and 26-20, which recognise different epitopes on the hydrophobic part of lipid A, also completely prevented priming of PMNL by either rough or smooth LPS. The dose-dependent inhibitory effect of both MAbs was similar to the inhibition by PMB. These results indicate that the binding of MAbs to the hydrophobic part of lipid A is important in blocking lipid A-mediated effects.
RyanJ. L. Microbial factors in pathogenesis: lipopoly-saccharides. In
RootR. K.,
SandeM. A.
(eds) Septic shock (Contemporary issues in infectious diseases, vol 4) New York: Churchill Livingstone; 198513–25
RietschelE. T.,
WollenweberH.-W.,
BradeH. Structure and conformation of the lipid A component of lipopolysaccharides. In
ProctorR. A.
(ed) Handbook of endotoxin vol 1 Amsterdam: Elsevier; 1984187–220
BaumgartnerJ. D.,
O’BrienT. X.,
KirklandT. N.,
GlauserM. P.,
ZieglerE. J. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5. J Infect Dis1987; 156:136–143
PollackM.,
ChiaJ. K. S.,
KolesN. L.,
MillerM.,
GueldeG. Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide. J Infect Dis1989; 159:168–188
SiberG. R.,
KaniaS. A.,
WarrenH. S. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria. J Infect Dis1985; 152:954–964
BaumgartnerJ.-D.,
GlauserM. P.,
McCutchanJ. A. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet1985; 2:59–63
McCabeW. R.,
DeMariaA.,
BerberichH.,
JohnsM. A. Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant. J Infect Dis1988; 158:291–300
ZieglerE. J.,
McCutchanJ. A.,
FiererJ. Treatment of gramnegative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med1982; 307:1225–1230
CalandraT.,
GlauserM. P.,
SchellekensJ. Verhoef J and the Swiss-Dutch J5 Immunoglobulin Study Group. Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. J Infect Dis1988; 158:312–319
ErichT.,
SchellekensJ.,
BouterA.,
van KranenJ.,
BrouwerE.,
VerhoefJ. Binding characteristics and cross-reactivity of three different antilipid A monoclonal antibodies. J Immunol1989; 143:4053–1060
ComelissenJ. J.,
OosterlakenT. A. M.,
SchellekensJ. Discrimination by rabbit anti-idiotypic antibodies of two murine IgM monoclonal antibodies directed against lipid A. J Immunol Methods1990; 130:141–147
FittschenC.,
SandhausR. A.,
WorthenG. S.,
HensonP. M. Bacteriallipopolysaccharide enhances chemoattractant-induced elastase secretion by human neutrophils. J Leukoc Biol1988; 43:547–556
GuthrieL. A.,
McPhailL. C.,
HensonP. M.,
JohnstonR. B. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med1984; 160:1656–1671
HaslettC.,
GuthrieL. A.,
KopaniakM. M.,
JohnstonR. B.,
HensonP. M. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol1985; 1:19101–110
BassD. A.,
OlbrantzP.,
SzejdaP.,
SeedsM. C.,
McCallC. E.Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol1986; 136:860–866
CraigW. A.,
TurnerJ. H.,
KuninC. M. Prevention of the generalized Shwartzman reaction and endotoxin lethality by polymyxin B localized in tissues. Infect Immun1974; 10:287–292
BoereW. A. M,
HarmsenT.,
VinjeJ.,
Benaissa-TrouwB. J.,
KraaijeveldC. A.,
SnippeH. Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities. J Virol1984; 52:575–582
ChenF. M.,
NaeveG. S.,
EpsteinA. L. Comparison of mono Q, superose-6, and ABx fast protein liquid chromatography for the purification of IgM monoclonal antibodies. J Chromatogr1988; 444:153–164
RemillardJ. F.,
GouldM. C.,
RoslanskyP. F.,
NovitskyT. J. Quantitation of endotoxin in products using the LAL kinetic turbidimetric assay. In
WatsonS. W.,
LewinJ.,
NovitskyT. J.Detection of bacterial endotoxins with the limulus amebocyte lysate test (Progress in clinical and biological research, vol 231.) New York: A. R. Liss; 1987197–210
HenricksP. A. J.,
Van der TolM. E.,
ThyssenR. M. W. M.,
van AsbeckS.,
VerhoefJ.Escherichia coli lipopolysaccharides diminish and enhance cell function of human polymorphonuclear leukocytes. Infect Immun1983; 41:294–301
LeiM.-G.,
MorrisonD. C. Specific lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations. J Immunol1988; 141:996–1005
LeiM.-G.,
MorrisonD. C. Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. II. Membrane localization and binding characteristics. J Immunol1988; 141:1006–1011
DannerR. L.,
JoinerK. A.,
ParrilloJ. E. Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3- Aza-lipid X. J Clin Invest1987; 80:605–612
CavaillonJ.-M.,
Haeffner-CavaillonN. Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human mono cytes is dependent upon the LPS origin. Mol Immunol1986; 23:965–969
DannerR. L.,
JoinerK. A.,
RubinM. Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide. Antimicrob Agents Chemother1989; 33:1428–1434